RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Emmanuel Akala to Paclitaxel

Back to Details
This is a "connection" page, showing publications Emmanuel Akala has written about Paclitaxel.
Emmanuel Akala
Connection Strength
1.165
Paclitaxel
  1. Berko YA, Akala EO. Computer Optimization of Stealth Biodegradable Polymeric Dual-loaded Nanoparticles for Cancer Therapy Using Central Composite Face-centered Design. Pharm Nanotechnol. 2020; 8(2):108-132.
    View in: PubMed
    Score: 0.693
  2. Adesina SK, Holly A, Kramer-Marek G, Capala J, Akala EO. Polylactide-based paclitaxel-loaded nanoparticles fabricated by dispersion polymerization: characterization, evaluation in cancer cell lines, and preliminary biodistribution studies. J Pharm Sci. 2014 Aug; 103(8):2546-55.
    View in: PubMed
    Score: 0.472
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support